Jul. 31 at 2:36 AM
$TARA is one to wait on, IMO. I've already made a lot on it during prior moves due to catalysts that have come and gone. I'm holding now for the bigger move I expect. I believe LM is going to be the big driver. Rarely do you see a situation where a cure is more sure than with TARA's treatment for LM. And what a need it meets in young people facing an awful stigma that can be taken away with TARA's treatment. With both Rare Pediatric Disease and Orphan drug designations; also Breakthrough Therapy and Fast Track designation....all for TARA-002 for LM, TARA is primed for success in a special need area that will be wonderful for all involved.
I think it largely explains the existence of 7 tiprank analysts, from Jones Trading, H.C Wainwright, Piper Sandler, LifeSci Capital, Oppenheimer, T.D. Cowen, and J.P. Morgan holding price targets from 24 to 28 (avg of 26/share). Four of these analysts are 5 star analysts and the other 3 are 4 to 4.5 star. That's impressive!! JMO
